CardioVis Selected for the 2026 Harvard HealthLab Accelerator Cohort
CardioVis has been selected for the 2026 Harvard HealthLab Accelerator cohort, advancing our mission to bring clinically meaningful AI support into cardiac surgery.
CardioVis is proud to announce its selection into the 2026 Harvard HealthLab Accelerator cohort, a critical milestone in our journey to redefine care in the operating room.
Healthcare is experiencing a transformation that seemed impossible just a few years ago. Our recognition by the Harvard HealthLab Accelerator supports our mission to develop a robot-integrated AI Copilot for cardiac surgery that delivers real-time intraoperative intelligence directly from surgical video and robotic data.
Transforming the Operating Room
We’re entering an era defined by ultra-personalized, predictive, and preventive care. Our platform is designed to support safer execution during critical operative moments through workflow awareness, targeted alerts, and clinically meaningful decision support. By bringing AI into the surgical suite, we are raising the standard of care.
The Harvard HealthLab Accelerator brings together high-potential ventures working at the intersection of innovation and health impact. For CardioVis, this opportunity will help accelerate product development, mentorship, and strategic growth as we advance toward clinically deployable solutions.
The Path Forward
The path forward requires holding two truths simultaneously: AI is driving essential healthcare innovation that improves lives, and we must deploy it responsibly. We are honored to join the 2026 cohort and look forward to building technology that helps make cardiac surgery more precise, informed, and resilient.